Neuron Specific Enolase as a Biomarker Predicting Neurological Outcome after Cardiac Arrest in Patients Treated by Therapeutic Hypothermia.
- Author:
Yu Jin JEUNG
1
;
Byung Kook LEE
;
Hyoung Youn LEE
;
Kyung Woon JEUNG
;
Hyun Ho RYU
;
Byeong Jo CHUN
;
Jeong Mi MOON
;
Tag HEO
;
Yong Il MIN
Author Information
1. Department of Emergency Medicine, School of Medicine, Chonnam National University, Gwangju, Korea. bbukkuk@hanmail.net
- Publication Type:Original Article
- Keywords:
Prognosis;
Outcome;
Heart arrest;
Induced hypothermia;
Neuron specific enolase
- MeSH:
Brain Injuries;
Dinucleoside Phosphates;
Heart Arrest;
Humans;
Hypothermia;
Hypothermia, Induced;
Neurons;
Phosphopyruvate Hydratase;
Prognosis;
ROC Curve;
Sensitivity and Specificity;
Survivors
- From:Journal of the Korean Society of Emergency Medicine
2012;23(1):15-23
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Neurological outcome prediction is an important aspect of post-resuscitation care in cardiac arrest survivors. The appearance of high serum neuron specific enolase (NSE) is known to be associated with ischemic brain injury and poor neurological outcome. The application of therapeutic hypothermia to cardiac arrest survivors has been shown to improve neurological outcomes. As such, we investigated the predictive value of serial serum NSE levels in patients who were resuscitated from cardiac arrest. METHODS: This study included 123 cardiac arrest survivors who were treated by therapeutic hypothermia from January 2008 to June 2011. Blood samples used for evaluating NSE were collected at return of spontaneous circulation (ROSC) at 6, 24 and 48 hours after initiation of therapeutic hypothermia. Neurological outcome was graded as 'good' or 'poor' at discharge and assessed according to the Cerebral Performance Category scale (CPC). A poor outcome was defined as a CPC value of 3-5. RESULTS: Receiver operating characteristic (ROC) analysis revealed NSE cut-off values of 53.9 microg/L (sensitivity 14.6%), 48.5 microg/L (sensitivity 30.6%), 80.0 microg/L (sensitivity 40.0%), and 52.7 microg/L (sensitivity 55.5%) for poor outcomes with a specificity of 100%, measured at ROSC of 6, 24 and 48 hours after initiation of therapeutic hypothermia, respectively. The poor outcome group showed significant change in NSE concentration over time (p=0.002), while the good outcome group did not. CONCLUSION: Detection of NSE at the cut-off value, 48 hr after initiation of therapeutic hypothermia was a specific but moderately sensitive marker of poor outcome at discharge. Single measurements of NSE should be cautiously interpreted, but NSE change over time was helpful in predicting the neurologic outcome.
